Kleerekooper, I., van Kempen, Z. L., Leurs, C. E., Dekker, I., Rispens, T., Lissenberg-Witte, B. I., . . . Killestein, J. (2017). Disease activity following pregnancy-related discontinuation of natalizumab in MS. Neurol Neuroimmunol Neuroinflamm.
Citação norma ChicagoKleerekooper, Iris, et al. "Disease Activity Following Pregnancy-related Discontinuation of Natalizumab in MS." Neurol Neuroimmunol Neuroinflamm 2017.
Citação norma MLAKleerekooper, Iris, et al. "Disease Activity Following Pregnancy-related Discontinuation of Natalizumab in MS." Neurol Neuroimmunol Neuroinflamm 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.